(Q34680420)

3 August 2017

title

Bilateral synchronous breast cancer and HER-2/neu overexpression (English)

1 reference

3 August 2017

1 reference

Eric S Hungness

4

1 reference

ORCID Public Data File 2021

Elyse E Lower

2

object named as

Elyse E Lower

1 reference

3 August 2017

8

Rawia Yassin

1 reference

3 August 2017

Malek Safal

1

1 reference

3 August 2017

P O Hasselgren

3

1 reference

3 August 2017

Paula Gazder

5

1 reference

3 August 2017

Bernard Aron

6

1 reference

3 August 2017

Elizabeth A Shaughnessy

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Breast Cancer Research and Treatment

3 August 2017

published in

1 reference

3 August 2017

volume

72

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

195-201

1 reference

Bilateral primary breast cancer: a prospective study of disease incidence.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

Radical excision of the chest wall for mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

Survival in bilateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

Prognosis in bilateral breast cancer. Effects of time interval between first and second primary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Bilateral breast carcinoma treated with definitive irradiation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Analysis of cerbB2 expression using a panel of 6 commercially available antibodies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Plasma membrane phosphotyrosine, Her2-NEU, and epidermal growth factor receptor in human breast cancer. A comparative study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Bilateral breast cancer in patients with initial stage I and II disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014958514851

7 January 2021

Identifiers

DOI

10.1023/A:1014958514851

1 reference

Dimensions Publication ID

3 August 2017

1040086518

0 references

1 reference